Contact this trialFirst, we need to learn more about you.
Angiotensin Receptor Blocker and Endothelin Receptor Antagonist
Sparsentan for Proteinuric Kidney Disease
Recruiting1 awardPhase 2
Durham, North Carolina
This trial is testing a drug to see if it is safe, works well, and is tolerated by patients. It will also assess how much protein is in urine after taking the drug.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.